Organon (OGN) Cash from Operations (2020 - 2026)

Organon (OGN) recorded quarterly Cash from Operations of 225000000.0 in Q1 2026, up 59.57% quarter-over-quarter from 141000000.0 in Q4 2025, and up 200.0% on a YoY basis from 75000000.0 in Q1 2025.

Organon (OGN) Cash from Operations (2020 - 2026) Analysis & Trends

Organon's Cash from Operations history runs 7 years deep, the most recent figure standing at 225000000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations rose 200.0% year-over-year to 225000000.0; the TTM figure through Mar 2026 stood at 850000000.0 (down 9.38% YoY), while the FY2025 annual figure was 700000000.0, down 25.45% from the prior year.
  • Cash from Operations was 225000000.0 for Q1 2026 at Organon, up from 141000000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 397000000.0 in Q4 2023 to a low of 27000000.0 in Q2 2023.
  • Historically, Cash from Operations has averaged 207117647.06 across 5 years, with a median of 220000000.0 in 2025.
  • The sharpest annual moves came in 2022 and 2024: Cash from Operations slumped 90.54% in 2022, then soared 1129.63% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 267000000.0 in 2022, then surged by 48.69% to 397000000.0 in 2023, then fell by 1.76% to 390000000.0 in 2024, then sank by 63.85% to 141000000.0 in 2025, then surged by 59.57% to 225000000.0 in 2026.
  • The last three Cash from Operations figures came in at 225000000.0 (Q1 2026), 141000000.0 (Q4 2025), and 264000000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 1.82 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 5.33 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 2.51 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 3.83 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 3.92 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 2.54 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 2.62 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 1.10 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 225.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 225.00 Mn
Mar 31, 2026 225.00 Mn
Dec 31, 2025 141.00 Mn
Dec 31, 2025 141.00 Mn
Sep 30, 2025 264.00 Mn
Sep 30, 2025 264.00 Mn
Jun 30, 2025 220.00 Mn
Jun 30, 2025 220.00 Mn
Mar 31, 2025 75.00 Mn
Mar 31, 2025 75.00 Mn
Dec 31, 2024 390.00 Mn
Dec 31, 2024 390.00 Mn
Sep 30, 2024 141.00 Mn
Sep 30, 2024 141.00 Mn
Jun 30, 2024 332.00 Mn
Jun 30, 2024 332.00 Mn
Mar 31, 2024 76.00 Mn
Mar 31, 2024 76.00 Mn
Dec 31, 2023 397.00 Mn
Dec 31, 2023 397.00 Mn